Advertisement

Understanding the Progression of Duchenne Muscular Dystrophy

How the symptoms of Duchenne muscular dystrophy (DMD) change as a person grows from childhood into young adulthood.

The first symptoms of DMD begin in early childhood, before the age of six.

A progressive disease is a disease or health condition that typically gets worse with time. Muscular dystrophies are described as progressive because the loss of muscle strength and muscle mass follow this progressive course, getting worse over time. Some muscular dystrophies progress slowly, others more quickly. Duchenne muscular dystrophy (DMD) is one of the most common types, and also a type of muscular dystrophy that typically progresses quickly.

The first symptoms of DMD begin in early childhood, before the age of six. It primarily occurs in males, and the condition is rare in females. (However, other types of muscular dystrophy occur at later ages, and affect both males and females).

For parents and caregivers of children who have DMD—or who are concerned about DMD and want to better understand the symptoms—it helps to understand how the disease begins and how it progresses.

How DMD affects the muscles

DMD is a genetic disorder. Genes are sections of DNA that contain instructions for assembling the many different chemical compounds that make up the human body. Many genes contain instructions for assembling different proteins.

DMD is caused by a mutation in the gene that contains instructions for assembling a protein called dystrophin. This protein is essential to the strength, repair, and other healthy functions of muscles—including skeletal muscles and cardiac muscles. Without dystrophin, these muscles break down and are replaced with fat tissue and scar tissue.

The progression of DMD

The course of DMD can vary from one person to the next. Many children with DMD appear to develop normally during infancy and early childhood, though there may be some delays. Signs of muscle weakness typically appear between the ages 2 to 3 years:

  • A child may have difficulty running, climbing stairs, and getting up from the floor.
  • Toe-walking, a waddling gait, and frequent falls may be observed.
  • There may also be delays in learning and cognitive development.

During preteen years (ages 6 through 12), muscle weakness and loss of muscle become more prominent and widespread, leading to difficulty with daily activities:

  • Scoliosis (abnormal curvature of the spine) may develop during this time.
  • Lung function may become impaired as a result of scoliosis, leading to breathing difficulty.
  • Children with DMD may require the use of mobility aids such as leg braces and wheelchairs.

Symptoms continue to progress during teenage years (ages 13 to 19). Cardiomyopathy (disease of the heart muscle) may develop during this time. The risk of respiratory complications also increases.

As a person ages from their teens into young adulthood (20s and 30s), mobility may be severely limited, and a person may require full-time care. A person may have a variety of additional healthcare needs to address mobility, breathing, cardiac function, nutrition, and other complications that occur as a result of having DMD.

Despite the challenges that come with DMD, it's important to remember that there are many resources and support systems available for families. People with DMD can live meaningful lives and enjoy fulfilling relationships with their loved ones.

Treatment options for people with DMD are improving, with multiple drugs and therapies approved in the past decade, and more treatments under development.

Article sources open article sources

NY Langone Health. Types of Muscular Dystrophy.
UpToDate. Patient education: Overview of muscular dystrophies (Beyond the Basics).
National Institute of Neurological Disorders and Stroke. Muscular Dystrophy.
National Organization for Rare Disorders. Duchenne Muscular Dystrophy.
MedlinePlus. Duchenne muscular dystrophy.
MedlinePlus. What is a gene?
MedlinePlus. How do genes direct the production of proteins?
MedlinePlus. DMD gene.
MedlinePlus. Duchenne muscular dystrophy.
Barbora Malecova, Sole Gatto, et al. Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy. Nature Communications, 2018. Vol. 9, No. 1.
Vijay Venugopal and Steven Pavlakis. Duchenne Muscular Dystrophy. StatPearls. July 11, 2022.
National Institute of Arthritis and Musculoskeletal and Skin Disorders. Scoliosis in Children and Teens.
Eliza Wasilewska, Sylwia Małgorzewicz, et al. Transition from Childhood to Adulthood in Patients with Duchenne Muscular Dystrophy. Medicina, 2020. Vol. 56, No. 9.

Featured Content

article

Duchenne Muscular Dystrophy and Caregiver Mental Health

If you are caring for a child with Duchenne muscular dystrophy, it’s important to care for yourself.
article

Early Signs and Symptoms of Duchenne Muscular Dystrophy

What parents need to know about the most common form of muscular dystrophy in children.
article

How Can Duchenne Muscular Dystrophy be Treated?

An overview of the treatments for this common form of muscular dystrophy, including exon-skipping therapy.
article

What Healthcare Providers Treat Duchenne Muscular Dystrophy?

A who’s who of the different members of the interdisciplinary team that treats Duchenne muscular dystrophy (DMD).
article

Questions About Duchenne Muscular Dystrophy Clinical Trials

What to ask your child’s healthcare providers about new treatments and clinical trials for Duchenne muscular dystrophy.